n/a
Article Publish Status: FREE
Abstract Title:

Nobiletin suppresses cholangiocarcinoma proliferation via inhibiting GSK3β.

Abstract Source:

Int J Biol Sci. 2022 ;18(15):5698-5712. Epub 2022 Sep 11. PMID: 36263164

Abstract Author(s):

Liping You, Jiacheng Lin, Zhuo Yu, Yihan Qian, Yuting Bi, Fang Wang, Lei Zhang, Chao Zheng, Jinghao Zhang, Wenxuan Li, Yaxuan Cai, Yueqiu Gao, Xiaoni Kong, Xuehua Sun

Article Affiliation:

Liping You

Abstract:

Cholangiocarcinoma (CCA) is a type of hepatobiliary cancer characterized by uncontrolled cell proliferation, with a poor prognosis and high mortality. Nobiletin (NBT) is a promising anti-tumor compound derived from the peels of oranges and other citrus plants, citrus plant. But the effect of NBT on CCA remains unknown.Our data showed that NBT suppressed CCA cell proliferationand. Colony formation and Edu assay indicated that NBT inhibited cell proliferation. Cell cycle analysis showed that NBT arrested the cell cycle in G0/G1 phase. Target prediction showed that GSK3β was a direct target. Western blot and immunofluorescence confirmed that NBT reduced the phosphorylation of GSK3β. The antiproliferative effect of NBT was intercepted in GSK3β knockdown CCA cells. The cellular thermal shift assay (CETSA) showed NBT directly bound to GSK3β. Finally, NBT showed an anti-proliferative effect in tumor-bearing mice with no hepatotoxicity.NBT could inhibit CCA proliferation, and the pharmacological activity of NBT in CCA was attributed to its direct binding to GSK3β. We suggested that NBT might be a potential natural medicine in CCA treatment.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.